Read the full stored bill text
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment.
*sb0336*
SENATE BILL 336
J1 6lr2062
CF HB 427
By: Senator Feldman
Introduced and read first time: January 23, 2026
Assigned to: Finance
Committee Report: Favorable with amendments
Senate action: Adopted
Read second time: February 16, 2026
CHAPTER ______
AN ACT concerning 1
Task Force on Responsible Use of Natural Psychedelic Substances – Extension 2
and Membership 3
FOR the purpose of extending the Task Force on Responsible Use of Natural Psychedelic 4
Substances to study and make recommendations related to the use of natural 5
psychedelic substances ; adding a representative of a historically Black college or 6
university in the State to the Task Force ; and generally relating to the Task Force 7
on Responsible Use of Natural Psychedelic Substances. 8
BY repealing and reenacting, with amendments, 9
Chapter 793 of the Acts of the General Assembly of 2024 10
Section 1 and 2 11
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 12
That the Laws of Maryland read as follows: 13
Chapter 793 of the Acts of 2024 14
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 15
That: 16
(a) (1) In this section, “natural psychedelic substances” includes naturally 17
derived psilocybin, psilocin, dimethyltryptamine, mescaline, and any other substance 18
determined by the Task Force to be a natural psychedelic substance. 19
2 SENATE BILL 336
(2) “Natural psychedelic substances” does not include peyote. 1
(b) There is a Task Force on Responsible Use of Natural Psychedelic Substances. 2
(c) The Task Force consists of the following members: 3
(1) one member of the Senate of Maryland who shall be appointed by the 4
President of the Senate; 5
(2) one member of the House of Delegates who shall be appointed by the 6
Speaker of the House; 7
(3) the Secretary of Health, or the Secretary’s designee; 8
(4) the Secretary of Disabilities, or the Secretary’s designee; 9
(5) the Secretary of Veterans Affairs, or the Secretary’s designee; 10
(6) the Director of the Maryland Cannabis Administration, or the 11
Director’s designee; and 12
(7) the following members, appointed by the Governor: 13
(i) one representative of the University System of Maryland, the 14
Johns Hopkins Universit y’s Center for Psychedelic and Consciousness Research, or 15
Sheppard Pratt; 16
(ii) ONE REPRESENTATIVE O F A HISTORICALLY BLACK 17
COLLEGE OR UNIVERSITY IN THE STATE; 18
(III) one representative of a Native American tribe with experience in 19
the religious and spiritual use of psychedelic substances; 20
(iii) (IV) one individual with expertise in behavioral health; 21
(iv) (V) one individual with expertise in the treatment of 22
substance use disorders; 23
(v) (VI) one individual with expertise in the treatment of chronic 24
pain; 25
(vi) (VII) one individual with expertise in psychedelic –assisted 26
psychotherapy; 27
(vii) (VIII) one individual with expertise in psychedelic research; 28
SENATE BILL 336 3
(viii) (IX) one individual with expertise in access to care in 1
underserved communities; 2
(ix) (X) one individual with expertise in drug policy reform; 3
(x) (XI) one individual with expertise as a member of law 4
enforcement; 5
(xi) (XII) one individual who is a patient with conditions that can be 6
treated with psychedelic substances; 7
(xii) (XIII) one individual with experience with the pharmacology of 8
natural psychedelic substances; and 9
(xiii) (XIV) one physician with experience with the appropriate use of 10
psychedelic substances and other integrative medical practices. 11
(d) To the extent practicable, the membership of the Task Force shall reflect the 12
socioeconomic, ethnic, and geographic diversity of the State. 13
(e) The Governor shall designate the chair of the Task Force. 14
(f) The Maryland Cannabis Administration shall provide staff for the Task Force. 15
(g) A member of the Task Force: 16
(1) may not receive compensation as a member of the Task Force; but 17
(2) is entitled to reimbursement for expenses under the Standard State 18
Travel Regulations, as provided in the State budget. 19
(h) The Task Force shall: 20
(1) study: 21
(i) existing laws, policies, and practices relating to the use of natural 22
psychedelic substances; 23
(ii) the best available science and data on public benefits of 24
responsible access to and use of natural psychedelic substances; 25
(iii) opportunities to maximize public benefits of responsible access to 26
and use of natural psychedelic substances; 27
(iv) the best available data on potential risks of access to and use of 28
natural psychedelic substances; 29
4 SENATE BILL 336
(v) opportunities to mitigate potential risks of access to and use of 1
natural psychedelic substances; and 2
(vi) barriers health care practitioners and facilitators may encounter 3
relating to natural psychedelic substances, including barriers relating to insurance, 4
restrictions by licensing and credentialing entities, zoning, advertising, and financial 5
services; 6
(2) make recommendations regarding any changes to State law, policy, and 7
practices needed to create a Maryland Natural Psychedelic Substance Access Program that 8
enables broad, equitable, and affordable access to psychedelic substances, including: 9
(i) permitting requirements, including requirements regarding 10
education and safety; 11
(ii) access to treatment and regulated support; and 12
(iii) production of natural psychedelic substances; and 13
(3) make recommendations to transition from criminalizing conduct 14
involving natural psychedelic substances, including: 15
(i) punishing with civil penalties nonviolent infractions involvin g 16
the planting, cultivating, purchasing, transporting, distributing, or possessing of or other 17
engagement with natural psychedelic substances; 18
(ii) expunging the records of Marylanders with convictions for 19
nonviolent criminal offenses relating to natural psychedelic substances; and 20
(iii) releasing Marylanders incarcerated for nonviolent criminal 21
offenses relating to natural psychedelic substances. 22
(i) The Task Force may consult with experts and stakeholders in conducting its 23
duties. 24
(j) (1) On or before July 31, 2025, the Task Force shall submit a report of its 25
findings and recommendations to the Governor and, in accordance with § 2 –1257 of the 26
State Government Article, the General Assembly. 27
(2) ON OR BEFORE OCTOBER 31, 2026, THE TASK FORCE SHALL 28
SUBMIT AN UPDATED RE PORT OF ITS FINDINGS AND RECOMMENDATIONS TO THE 29
GOVERNOR AND , IN ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT 30
ARTICLE, THE GENERAL ASSEMBLY. 31
SENATE BILL 336 5
SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 1
1, 2024. It shall remain effective for a period of [2] 3 years and 6 months and, at the end of 2
December 31, [2026] 2027, this Act, with no further action required by the General 3
Assembly, shall be abrogated and of no further force and effect. 4
SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 5
1, 2026. 6
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
President of the Senate.
________________________________________________________________________________
Speaker of the House of Delegates.